Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa

Artemisinin-based combination therapies (ACT) are currently used as a first-line malaria therapy in endemic countries worldwide. This systematic review aims at presenting the current scenario of drug resistance molecular markers, either selected or involved in treatment failures (TF) during in vivo...

Descripción completa

Detalles Bibliográficos
Autores principales: Arya, Aditi, Kojom Foko, Loick P., Chaudhry, Shewta, Sharma, Amit, Singh, Vineeta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Regular article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887327/
https://www.ncbi.nlm.nih.gov/pubmed/33556786
http://dx.doi.org/10.1016/j.ijpddr.2020.11.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887327/
https://www.ncbi.nlm.nih.gov/pubmed/33556786
http://dx.doi.org/10.1016/j.ijpddr.2020.11.006

Ejemplares similares